Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-09-08
1995-12-19
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544345, A61K 31495, C07D23726
Patent
active
054768519
ABSTRACT:
This invention relates to pyrazolo[3,4-g]quinoxaline compounds exhibiting protein tyrosine kinase inhibition activity of the formula: ##STR1## where: ------ may be a double bond;
REFERENCES:
patent: 4954498 (1990-09-01), Mertens et al.
patent: 5075306 (1991-12-01), Jacobsen et al.
Venugopalan et al., Indian Journal of Chemistry, 29B, Apr. 1990, pp. 364-365.
Ly Cuong Q.
Myers Michael R.
Persons Paul E.
Spada Alfred P.
Grumbling Matthew V.
Nicholson James A.
Parker III Raymond S.
Rhone-Poulenc Rorer Pharmaceuticals Inc.
Savitzky Martin F.
LandOfFree
Pyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-992227